However, further clinical studies on various human cancers in combination with different standard chemotherapy regimens showed no remarkable synergistic anti-cancer effects (7–9), and in a trial for treatment of non-small cell lung cancer, TRAIL plus chemotherapy only moderately prolonged progression free survival (PFS) (10). Here, TNFSF10 is linked to cancer.